Clinical Trial Update: A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome [NA]

View source ↗

Summary

A double-blind, placebo-controlled clinical trial evaluated intravenous ribavirin as a treatment for presumed Hantavirus Pulmonary Syndrome; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hantavirus Pulmonary Syndrome

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hantavirus Pulmonary Syndrome | NA | Status: COMPLETED